NLRP3 and depressive disorder: Inhibition of hippocampal NLRP3 inflammasome activation by MCC950—a small-molecule inhibitor of the NLRP3 inflammasome—improved cognitive dysfunction as well as anxiety- and depression-like behaviors in db/db mice, thus offering an effective potential therapeutic approach for DEP treatment.